1. Home
  2. ATI vs LNTH Comparison

ATI vs LNTH Comparison

Compare ATI & LNTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo ATI Inc.

ATI

ATI Inc.

HOLD

Current Price

$112.96

Market Cap

11.2B

Sector

Industrials

ML Signal

HOLD

Logo Lantheus Holdings Inc.

LNTH

Lantheus Holdings Inc.

HOLD

Current Price

$65.95

Market Cap

4.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ATI
LNTH
Founded
1960
1956
Country
United States
United States
Employees
N/A
N/A
Industry
Steel/Iron Ore
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
11.2B
4.4B
IPO Year
N/A
2015

Fundamental Metrics

Financial Performance
Metric
ATI
LNTH
Price
$112.96
$65.95
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
7
6
Target Price
$105.43
$78.00
AVG Volume (30 Days)
1.5M
1.1M
Earning Date
02-03-2026
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
18.88
N/A
EPS
3.10
2.39
Revenue
$4,583,000,000.00
$1,525,933,000.00
Revenue This Year
$6.49
$0.01
Revenue Next Year
$8.40
$1.24
P/E Ratio
$35.39
$27.10
Revenue Growth
7.75
1.95
52 Week Low
$39.23
$47.25
52 Week High
$111.22
$111.29

Technical Indicators

Market Signals
Indicator
ATI
LNTH
Relative Strength Index (RSI) 74.07 67.15
Support Level $107.10 $64.13
Resistance Level $110.85 $67.01
Average True Range (ATR) 3.28 2.17
MACD 0.66 0.32
Stochastic Oscillator 93.91 83.73

Price Performance

Historical Comparison
ATI
LNTH

About ATI ATI Inc.

ATI Inc supplies specialty metals to various end markets, including aerospace and defense, oil and gas, automotive, and electrical energy, among many others. The company's operating segment includes High-Performance Materials and Components and Advanced Alloys and Solutions. The majority of revenue is from the High-Performance Materials segment. The High-Performance Materials segment is focused on a wide range of high-performance specialty materials, parts, and components for several the majority of end markets, including the aerospace & defense, medical, and energy markets. Geographically, it operates in the United States, China, the United Kingdom, Germany, France, Canada, and Others, the majority is from the United States.

About LNTH Lantheus Holdings Inc.

Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products. Its products are in three categories: Precision Diagnostics, Radiopharmaceutical Oncology, and Strategic Partnerships and Other Revenue. Precision Diagnostic products assist healthcare professionals Find and Follow diseases, with a focus in cardiology. Radiopharmaceutical Oncology diagnostics and therapeutics help HCPs Find, Fight and Follow cancer. Strategic Partnerships focus on enabling precision medicine through the use of biomarkers, digital solutions and pharma services platforms, and also includes license of RELISTOR to Bausch Health Companies, Inc.

Share on Social Networks: